Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • The Ponce de Leon Ctr. CRS Atlanta, Georgia, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
View all 13 locations
View Trial Details
Completed

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

NCT00015652

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Univ. of Iowa Healthcare, Div. of Infectious Diseases Iowa City, Iowa, United States
View Trial Details
Completed

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

NCT00001067

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Howard University Hosp., Div. of Infectious Diseases, ACTU Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details
Completed

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

NCT00011479

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham - Pediatric Birmingham, Alabama, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Children's Hospital of L.A. (Pediatric) Los Angeles, California, United States
  • Univ of California, San Diego San Diego, California, United States
View all 24 locations
View Trial Details
Completed

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

NCT00125983

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • USC CRS Los Angeles, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View Trial Details
Completed

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

NCT00051831

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States
  • Washington U CRS St Louis, Missouri, United States
  • NY Univ. HIV/AIDS CRS New York, United States
View Trial Details
Completed

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

NCT00001087

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Northwestern University CRS Chicago, Illinois, United States
  • Cook County Hosp. CORE Ctr. Chicago, Illinois, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
View Trial Details
Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers

NCT00001090

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • JHU AVEG Baltimore, Maryland, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
View Trial Details
Completed

A Study of HIV-Disease Development in Aging

NCT00006144

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Santa Clara Valley Med. Ctr. San Jose, California, United States
View all 45 locations
View Trial Details

Related conditions